NCT00201266View on ClinicalTrials.gov

Histoblood Group Antigens as a Risk Factor of Asthma

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

August 31, 2011

Conditions
AsthmaLung Diseases
Interventions
PROCEDURE

Screening

Characterization tests including blood group typing, measures of lung function, measures of allergy, and collection of DNA.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, San Francisco

OTHER

NCT00201266 - Histoblood Group Antigens as a Risk Factor of Asthma | Biotech Hunter | Biotech Hunter